CSIMarket Company Name, Ticker, Suppliers, else..
 
Scorpius Holdings inc   (SCPX)
 
Price: $0.0060 $0.00 0.000%
Day's High: $0.006000000052154064 Week Perf: 445.45 %
Day's Low: $ 0.01 30 Day Perf: 400 %
Volume (M): 0 52 Wk High: $ 0.10
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.01 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 61
 Employees -
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Business Description


Through its subsidiary Scorpius Biomanufacturing, Inc., the company operates as a contract development and manufacturing organization (CDMO) providing biologics manufacturing services. These services include process development, cGMP clinical and commercial manufacturing for the biotechnology and biopharmaceutical industries. The company specializes in biomanufacturing cell- and gene-based therapies and large molecule biologics, using American-made equipment and materials. It operates a facility in San Antonio, Texas, and offers drug substance manufacturing, release and stability testing, and various process development services.


   Company Address: 1305 East Houston Street San Antonio 78205 TX
   Company Phone Number: 201-5050   Stock Exchange / Ticker: SCPX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Shares

Scorpius Holdings Implements Reverse Stock Split to Strengthen Market Compliance Following 50% Share Price Decline,

Published Thu, Jan 16 2025 9:05 PM UTC

Scorpius Holdings Boosts Compliance Efforts with 1-for-20 Reverse Stock Split: A Strategic Move Amid Market ChallengesIn a significant move aimed at strengthening its market presence, Scorpius Holdings, Inc. (NYSE American: SCPX), a prominent integrated contract development and manufacturing organization (CDMO), announced on January 16, 2025, that its Board of Directors has ...
Shares

Scorpius Holdings Abandons Reverse Stock Split: A Retreat Amidst Falling Shares

Published Fri, Jan 17 2025 8:13 PM UTC

Scorpius Holdings, Inc. an integrated contract development and manufacturing organization (CDMO) based in Durham, North Carolina, has canceled its previously announced 1-for-20 reverse stock split following a swift reconsideration by its Board of Directors. The announcement, made on January 17, 2025, has raised eyebrows among investors who had only recently been informed of ...
Product Service News

Scorpius Holdings Accelerates Biotech Innovation with Strategic Launch and Infrastructure Expansion

Published Tue, Nov 19 2024 12:30 PM UTC

As the biotechnology sector pushes for increased domestic capacity and innovation, Scorpius Holdings, Inc. (NYSE American: SCPX) has made significant strides with the launch of its new business unit, Scorpius Ventures. This initiative aims to support up-and-coming biotech companies through a flexible equity-based onshoring model, which aligns closely with the s of the BIOSE...
Partnership

Biologics Evolution Scorpius Holdings’ Strategic Alliance with Celltheon Corporation Signals a New Era ...

Published Mon, Nov 4 2024 12:31 PM UTC

In a significant move set to reshape the landscape of biopharmaceutical manufacturing, Scorpius Holdings, Inc. (NYSE American: SCPX) recently announced a strategic partnership with Celltheon Corporation, a leading U.S.-based cell line development company. This collaboration underscores Scorpius Holdings commitment to expanding its technological capabilities and offering enh...
Management Announcement

Scorpius Holdings Launches Cost-Cutting Initiatives Amid Ongoing Profitability Challenges

Published Thu, Oct 31 2024 11:30 AM UTC

In a strategic move aimed at bolstering its financial health, Scorpius Holdings Inc. has announced the implementation of significant cost savings measures projected to save the company over $2 million annually. This decision follows a troubling financial trajectory, during which Scorpius recorded a cumulative net loss of $28 million in the 12 months ending in the second quar...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.21
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.03
Working Capital Ratio 0.1
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -5.01 $
Revenues (TTM) 0.03 $
Cash Flow (TTM) -
Cash 0.01 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) 12.3
Inventory Turnover Ratio (TTM) 6.44
Asset Turnover Ratio (TTM) 0.07

Profitability Ratios Current
Gross Margin (MRQ) 36.75 %
Operating Margin (MRQ) -2056.82 %
Net Margin (MRQ) -521.91 %
Net Cash Flow Margin (MRQ) 26.58 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Scorpius Holdings Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.